ASN
CHRS icon

Advisory Services Network’s Coherus Oncology CHRS Stock Holding History

Advisory Services Network’s Portfolio CHRS Stock Details CHRS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q1 		– Sell
-9,150
Closed -$30.5K – 1831
2023
Q4 		$30.5K Sell
9,150
-4,300
-32% -$11.5K ﹤0.01% 2283
2023
Q3 		$50.3K Sell
13,450
-200
-1% -$924 ﹤0.01% 1443
2023
Q2 		$58.3K Buy
13,650
+2,750
+25% +$16.2K ﹤0.01% 1405
2023
Q1 		$74.6K Buy
10,900
+1,350
+14% +$10.5K ﹤0.01% 1809
2022
Q4 		$75.6K Buy
+9,550
New +$73.5K ﹤0.01% 1753
2021
Q4 		– Sell
-10,350
Closed -$166K – 1413
2021
Q3 		$166K Sell
10,350
-3,550
-26% -$52K 0.01% 1299
2021
Q2 		$192K Buy
13,900
+350
+3% +$4.96K 0.01% 1287
2021
Q1 		$198K Sell
13,550
-43,775
-76% -$743K 0.01% 1187
2020
Q4 		$996K Buy
57,325
+1,445
+3% +$25.7K 0.04% 504
2020
Q3 		$1.02M Buy
55,880
+7,515
+16% +$140K 0.05% 404
2020
Q2 		$864K Buy
48,365
+9,405
+24% +$159K 0.05% 425
2020
Q1 		$632K Buy
38,960
+11,505
+42% +$213K 0.04% 456
2019
Q4 		$494K Buy
+27,455
New +$506K 0.03% 625

Other funds holding CHRS

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
RCMNY
Rubric Capital Management (New York) New York $9.44B AUM 68.42% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Temasek Holdings
Temasek Holdings Singapore $30.5B AUM 13.98% 1-Year Est. Return
KKRC
Kohlberg Kravis Roberts & Co New York $5.35B AUM 63.01% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Barclays
Barclays London, United Kingdom $416B AUM 33.63% 1-Year Est. Return

Advisory Services Network's CHRS Position: Q1 2024 in Review

Advisory Services Network sold out of Coherus Oncology (CHRS) in Q1 2024, closing a stake of 9,150 shares — an estimated $30.5K sold.

Advisory Services Network first reported a position in CHRS in Q4 2019 and held it in 13 quarters. The position peaked at $1.02M in Q3 2020. 137 funds tracked by Wall St. Rank hold CHRS as of Q1 2024.

  • Advisory Services Network reported no remaining Coherus Oncology position as of Q1 2024 after selling out during the quarter.
  • Advisory Services Network sold 9,150 Coherus Oncology shares in Q1 2024, an estimated $30.5K.
  • Advisory Services Network first reported a position in Coherus Oncology in Q4 2019 and held it in 13 quarters.
  • Advisory Services Network's Coherus Oncology position peaked at $1.02M in Q3 2020.
  • 137 funds tracked by Wall St. Rank held Coherus Oncology as of Q1 2024.

Based on Advisory Services Network's 13F filing for Q1 2024, filed 6 May 2024.